National and Kapodistrian University of Athens
Περιφερική νευροπάθεια σε παιδιά και εφήβους με ινσουλινοεξαρτώμενο σακχαρώδη διαβήτη
Abstract
dc:descriptionIntroduction: Diabetic neuropathy (DN) is a common complication of type 1 diabetes mellitus (T1DM) in adulthood, whereas it is rare as a clinical problem during childhood. However, impaired indices of neural function have also been reported in T1DM children and adolescents. The quality of metabolic control is the most important modifiable risk factor for the development of DN, which seems to have a multifactorial aetiology, not fully clarified yet. Glutamic acid decarboxylase (GADΑ) and islet antigen-2 (IA-2Α) antibodies are major β-cell antibodies in T1DM. GADA antibodies have also been associated to the development of various neurologic diseases, while the role of GADA and IA-2A in the development of DN remains controversial. Aims: The aim of the present study was the assessment of the prevalence of impaired early indices of large myelinated nerve fiber dysfunction in T1DM children and adolescents. An additional target was the investigation of possible correlations of incipient DN with different parameters, such as age, gender, height, puberty, T1DM duration, metabolic control or other diabetic complications (early nephropathy or retinopathy). Moreover, in T1DM patients the presence of GADA and IA-2A was recorded and their possible association with indices of nerve dysfunction was investigated. Materials and methods: The study population consisted of 129 T1DM patients aged >8 years, with a disease duration of >2 years and 129 healthy control subjects. A complete physical and neurological examination was conducted in every subject. In T1DM patients, metabolic control was assessed with the calculation of mean HbA1c value (average of the last year’s HbA1c recordings). Persistent microalbuminuria and abnormal findings in fundoscopy were used as indices of early nephropathy and retinopathy, respectively. Blood samples were collected from the patients for the estimation of GADA and IA-2A levels. Vibration sensation threshold (VST) as an index of peripheral DN was measured in both patients and controls in thumb, index finger, toe and hallux using a biothesiometer. As far as the patients were concerned, nerve conduction studies (NCS) were performed for the electrophysiological examination of median, peroneal and sural nerves. VST abnormality for each examination site was defined as values exceeding the 95% confidence interval of the controls’ measurements (the upper normal limit).Results: Patients, although asymptomatic in the vast majority (96.1%), had significantly elevated VST values in the upper and lower limbs compared to controls. Almost half of the patients (44.5%) had abnormal VST values in at least one site, more frequently in the lower limbs. Abnormal NCS was recorded in 34.1% of the patients, mainly in sensory peroneal nerve. The presence of GADA, IA-2A and double antibody positivity were recorded in 62.7%, 58.7% and 42.4% of the patients respectively. VST or NCS abnormality did not correlate with gender, age, T1DM duration, diabetic control, the presence of other diabetic complications or the presence of GADA or IA-2A autoantibodies. However, patients with positive GADA or IA-2A had lower compound nerve action potential (CNAP) in the sensory peroneal nerve (p=0.046 and p=0.002, respectively), indicative of axonal dysfunction. Additionally, a progressive reduction in peroneal action potentials (both sensory and motor) was observed in parallel with the increase of the number of positive autoantibodies (GADA and/or IA-2A). On the contrary, patients with no antibody positivity had better sural CNAP. Conclusively, the presence of one or both of the examined autoantibodies GADA and IA-2A was associated with axonal dysfunction in the lower limbs. Conclusions: The results of the present study indicate that subclinical DN is frequent among T1DM children and adolescents, irrespectively of disease duration or the quality of metabolic control. Thus early diagnosis of nerve dysfunction is of major importance. The association of the presence of GADA and IA-2A autoantibodies with indices of early axonal dysfunction in T1DM children and adolescents is reported for the first time. Future studies may reveal the exact pathways through which the above autoantibodies are involved in the development of axonal degeneration observed early in the course of diabetic neuropathy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Louraki, Maria
- Λουράκη, Μαρία
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38767